Paclitaxel After Doxorubicin Plus Cyclophosphamide As Adjuvant Chemotherapy for Node-Positive Breast Cancer: Results From NSABP B-28

P. Mamounas, Eleftherios; Bryant, John; C. Lembersky, Barry; Fehrenbacher, Louis; Sedlacek, Scot; Fisher, Bernard; Lawrence Wickerham, D.; Yothers, Greg; Soran, Atilla; Wolmark, Norman

doi:10.1200/jco.2005.10.517

Public

Paclitaxel After Doxorubicin Plus Cyclophosphamide As Adjuvant Chemotherapy for Node-Positive Breast Cancer: Results From NSABP B-28

Published in Journal of Clinical Oncology • May 17, 2005

Authors:

Eleftherios P. Mamounas

John Bryant

Barry C. Lembersky

Abstract

PURPOSE: The primary aim of National Surgical Adjuvant Breast and Bowel Project (NSABP) B-28 was to determine whether four cycles of adjuvant paclitaxel (PTX) after four cycles of adjuvant doxorubicin/cyclophosphamide (AC) will prolong disease-free survival (DFS) and overall survival (OS) compared w...

Subject

Medicine

Breast cancer

Cyclophosphamide

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!